Stock MBX MICROBIX BIOSYSTEMS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Microbix Biosystems Inc.

Equities

MBX

CA59501P1045

Delayed Toronto S.E.
Other stock markets
 19:21:47 09/05/2024 BST 		5-day change 1st Jan Change
0.33 CAD 0.00% Intraday chart for Microbix Biosystems Inc. -1.49% -15.38%
04-25 Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology MT
04-25 Microbix Collaborator Introduces New Lab Accreditation Program CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Microbix Collaborator Introduces New Lab Accreditation Program
Microbix?S Clot-Buster Drug Project Advances
Microbix Biosystems Inc. Unveils Test Controls for Head and Neck Cancer
Microbix Higher After Reporting Record Results for Q1 Fiscal 2024
Microbix Biosystems Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen
Microbix Reports Q4 Income of $2 Million
Microbix Biosystems Inc. Provides Earnings Guidance for the Full-Year Fiscal 2024
Microbix Biosystems Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Microbix Biosystems Inc. Announces A Collaboration with Seegene USA, Inc
Microbix Biosystems Inc. and BioGX, Inc. Collaborate on Real-Time PCR Assays & Controls
Microbix Biosystems Inc. announces an Equity Buyback for 6,827,518 shares, representing 5% of its issued share capital.
Microbix Biosystems Inc. authorizes a Buyback Plan.
Microbix Says 'Clot-Buster' Drug Fully-Funded For Return to U.S. Market; Will Influence Co's Results In Q4 FY23 and Q1 FY24
Microbix Biosystems Inc. Announces Collaboration with Ulisse Biomed S.P.A
Microbix Biosystems Says Quality Assessment Products to Support HPV Testing in Ireland; Down 3.4%
Microbix Biosystems Inc. QAPs Supporting HPV Testing in Ireland
Microbix Says Achieved New QAPs Sales Record; Cites Over C$1 Million in Orders from Leading Diagnostics Industry Test-Maker
Microbix Biosystems Inc. Achieves New QAPs Sales Record
Microbix Reports Q3 Revenue of $5.5 Million
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MBX Stock
  4. News Microbix Biosystems Inc.
  5. Other languages